Fingerprint
Dive into the research topics of 'A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients with Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically